Vericity, Inc. (NASDAQ:VERY – Get Free Report) major shareholder Holdco L.P. Apex sold 11,373,352 shares of the stock in a transaction on Friday, June 28th. The shares were sold at an average price of $11.43, for a total value of $129,997,413.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Vericity Price Performance
VERY opened at $11.43 on Wednesday. Vericity, Inc. has a 12-month low of $4.70 and a 12-month high of $12.14. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $170.08 million, a P/E ratio of -12.42 and a beta of 0.13. The stock has a fifty day moving average of $11.34 and a 200-day moving average of $11.32.
Vericity (NASDAQ:VERY – Get Free Report) last posted its quarterly earnings results on Wednesday, May 15th. The company reported ($0.37) earnings per share for the quarter. Vericity had a negative return on equity of 12.99% and a negative net margin of 7.59%. The company had revenue of $45.49 million during the quarter.
Hedge Funds Weigh In On Vericity
About Vericity
Vericity, Inc, together with its subsidiaries, provides life insurance protection products for the middle American market. The company operates through Agency and Insurance segments. The Agency segment sells life insurance products for unaffiliated insurance companies through its call center distribution platform, as well as through its independent agents and other marketing organizations.
Read More
- Five stocks we like better than Vericity
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- RXO Shares Surge Following New Acquisition Deal
- Trading Stocks: RSI and Why it’s Useful
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Golden Cross Stocks: Pattern, Examples and Charts
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Vericity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vericity and related companies with MarketBeat.com's FREE daily email newsletter.